BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30988666)

  • 1. Identification of prothymosin alpha (PTMA) as a biomarker for esophageal squamous cell carcinoma (ESCC) by label-free quantitative proteomics and Quantitative Dot Blot (QDB).
    Zhu Y; Qi X; Yu C; Yu S; Zhang C; Zhang Y; Liu X; Xu Y; Yang C; Jiang W; Tian G; Li X; Bergquist J; Zhang J; Wang L; Mi J
    Clin Proteomics; 2019; 16():12. PubMed ID: 30988666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTMA binds to HMGB1 to regulate mitochondrial oxidative phosphorylation and thus affect the malignant progression of esophageal squamous cell carcinoma.
    Chen S; He R; Lin X; Zhang W; Chen H; Xu R; Kang M
    J Thorac Dis; 2023 Mar; 15(3):1302-1318. PubMed ID: 37065565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method.
    Zhao J; Fan YX; Yang Y; Liu DL; Wu K; Wen FB; Zhang CY; Zhu DY; Zhao S
    Int J Clin Exp Pathol; 2015; 8(2):1535-44. PubMed ID: 25973038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the up-regulation of TP-alpha, collagen alpha-1(VI) chain, and S100A9 in esophageal squamous cell carcinoma by a proteomic method.
    Fan NJ; Gao CF; Wang CS; Zhao G; Lv JJ; Wang XL; Chu GH; Yin J; Li DH; Chen X; Yuan XT; Meng NL
    J Proteomics; 2012 Jul; 75(13):3977-86. PubMed ID: 22583932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis.
    Zhu X; Ding M; Yu ML; Feng MX; Tan LJ; Zhao FK
    BMC Cancer; 2010 Jun; 10():290. PubMed ID: 20546628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome.
    Kashyap MK; Harsha HC; Renuse S; Pawar H; Sahasrabuddhe NA; Kim MS; Marimuthu A; Keerthikumar S; Muthusamy B; Kandasamy K; Subbannayya Y; Prasad TS; Mahmood R; Chaerkady R; Meltzer SJ; Kumar RV; Rustgi AK; Pandey A
    Cancer Biol Ther; 2010 Oct; 10(8):796-810. PubMed ID: 20686364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of PA28β as a potential novel biomarker in human esophageal squamous cell carcinoma.
    Chen JY; Xu L; Fang WM; Han JY; Wang K; Zhu KS
    Tumour Biol; 2017 Oct; 39(10):1010428317719780. PubMed ID: 29020885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin-Linked Kinase Is Involved In the Proliferation and Invasion of Esophageal Squamous Cell Carcinoma.
    Ning Z; Zhu X; Jiang Y; Gao A; Zou S; Gu C; He C; Chen Y; Ding WQ; Zhou J
    J Cancer; 2020; 11(2):324-333. PubMed ID: 31897228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-messenger RNA regulatory network of esophageal squamous cell carcinoma and the identification of miR-1 as a biomarker of patient survival.
    Wei Q; Li X; Yu W; Zhao K; Qin G; Chen H; Gu Y; Ding F; Zhu Z; Fu X; Sun M
    J Cell Biochem; 2019 Aug; 120(8):12259-12272. PubMed ID: 31017699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDLIM5 identified by label-free quantitative proteomics as a potential novel biomarker of papillary thyroid carcinoma.
    Wei X; Zhang Y; Yu S; Li S; Jiang W; Zhu Y; Xu Y; Yang C; Tian G; Mi J; Bergquist J; Zhao M; Song F
    Biochem Biophys Res Commun; 2018 May; 499(2):338-344. PubMed ID: 29574154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of prothymosin alpha predicts poor disease outcome in head and neck cancer.
    Tripathi SC; Matta A; Kaur J; Grigull J; Chauhan SS; Thakar A; Shukla NK; Duggal R; Choudhary AR; Dattagupta S; Sharma MC; Ralhan R; Siu KW
    PLoS One; 2011 May; 6(5):e19213. PubMed ID: 21573209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minichromosome maintenance 6 complex component identified by bioinformatics analysis and experimental validation in esophageal squamous cell carcinoma.
    Li X; Ren Z; Xiong C; Geng J; Li Y; Liu C; Ren C; Liu H
    Oncol Rep; 2020 Sep; 44(3):987-1002. PubMed ID: 32583000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of HLA-DQA1 predicts poor outcome in patients with esophageal squamous cell carcinoma in Northern China.
    Shen FF; Pan Y; Li JZ; Zhao F; Yang HJ; Li JK; Gao ZW; Su JF; Duan LJ; Lun SM; Zhang P; Tian LQ; Sun G; Huang D; Cao YT; Zhou FY
    Medicine (Baltimore); 2019 Feb; 98(8):e14454. PubMed ID: 30813145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative dot blot analysis (QDB), a versatile high throughput immunoblot method.
    Tian G; Tang F; Yang C; Zhang W; Bergquist J; Wang B; Mi J; Zhang J
    Oncotarget; 2017 Aug; 8(35):58553-58562. PubMed ID: 28938578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated maspin expression is associated with better overall survival in esophageal squamous cell carcinoma (ESCC).
    Wang Y; Sheng S; Zhang J; Dzinic S; Li S; Fang F; Wu N; Zheng Q; Yang Y
    PLoS One; 2013; 8(5):e63581. PubMed ID: 23717449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of NS1-BP expression in esophageal squamous cell carcinoma].
    Ren K; Qian D; Wang YW; Pang QS; Zhang WC; Yuan ZY; Wang P
    Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):21-27. PubMed ID: 29365413
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased expression of prothymosin-α, independently or combined with TP53, correlates with poor prognosis in colorectal cancer.
    Zhang M; Cui F; Lu S; Lu H; Jiang T; Chen J; Zhang X; Jin Y; Peng Z; Tang H
    Int J Clin Exp Pathol; 2014; 7(8):4867-76. PubMed ID: 25197357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma.
    Zhang H; Duan CJ; Zhang H; Cheng YD; Zhang CF
    Asian Pac J Cancer Prev; 2013; 14(5):2851-7. PubMed ID: 23803043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated p53 expression levels correlate with tumor progression and poor prognosis in patients exhibiting esophageal squamous cell carcinoma.
    Huang K; Chen L; Zhang J; Wu Z; Lan L; Wang L; Lu B; Liu Y
    Oncol Lett; 2014 Oct; 8(4):1441-1446. PubMed ID: 25202347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. iTRAQ-based quantitative proteomic analysis of esophageal squamous cell carcinoma.
    Deng F; Zhou K; Li Q; Liu D; Li M; Wang H; Zhang W; Ma Y
    Tumour Biol; 2016 Feb; 37(2):1909-18. PubMed ID: 26330293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.